Deadlines are 5:00 PM (Eastern). No extensions will be granted.
Please click on the “RFA ANNOUNCEMENT” link in the upper right corner for more information.
JDRF Canadian Clinical Trial Network (“JDRF CCTN,” www.jdrf.ca/cctn) is a platform that has been established for clinical research to test new treatments and technologies for type 1 diabetes (T1D). JDRF CCTN is pleased to announce a gift of $3.5 million from the WB Family Foundation (WBFF) that is intended to support additional research opportunities in Canada to focus efforts aimed at curing T1D.
JDRF CCTN/WBFF Translational Program To A Cure Awards will be supported up to a maximum of $1.5 million CAD total costs over 3 years. Emphasis will be placed on clinical translation efforts that pursue a cure for T1D. Applications may include more than one project, and may include pre-clinical research with the direct potential to lead to clinical trials. Collaborations among institutions, investigators, individuals and industry, especially those intended to take advantage of and build upon JDRF CCTN infrastructure, are encouraged. Programs that build upon ongoing JDRF CCTN activities are welcome.
This program is available to investigators who are based at Canadian institutions and may be from academic institutions or industry. Although principal investigators must be at a Canadian institution and of Canadian Nationality, collaborators from outside of Canada may be funded as part of an overall application.